December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sanara MedTech Inc. - Common Stock (NQ:SMTI)

20.81 -0.69 (-3.21%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 48,928
Open 21.82
Bid (Size) 20.00 (300)
Ask (Size) 23.60 (200)
Prev. Close 21.50
Today's Range 20.47 - 21.82
52wk Range 16.05 - 35.95
Shares Outstanding 8,935,657
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Sanara MedTech (SMTI) Q1 2026 Earnings Transcript ↗
Sanara MedTech (SMTI) Q1 2026 Earnings Transcript 
Via The Motley Fool
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI
From Pomerantz LLP
Via GlobeNewswire

Performance

YTD
-9.9%
-9.9%
1 Month
+1.8%
+1.8%
3 Month
+9.0%
+9.0%
6 Month
-13.7%
-13.7%
1 Year
-28.1%
-28.1%

More News

Read More
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI
From Pomerantz LLP
Via GlobeNewswire
Sanara MedTech Inc. (NASDAQ:SMTI) Stock Slides on Q4 2025 Earnings Miss Despite Reaffirmed 2026 Outlook ↗
Via Chartmill
Topics Earnings
News headline image
Earnings Scheduled For November 12, 2025 ↗
Via Benzinga
News headline image
SMTI Investors Have Opportunity to Join Sanara MedTech Inc. Fraud Investigation with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
Sanara MedTech (SMTI) Q4 2025 Earnings Transcript ↗
Via The Motley Fool
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI
From Pomerantz LLP
Via GlobeNewswire
News headline image
Securities Fraud Investigation Into Sanara MedTech Inc. (SMTI) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
Sanara MedTech Inc. (SMTI) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
Securities Fraud Investigation Into Sanara MedTech Inc. (SMTI) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
From Law Offices of Frank R. Cruz
Via Business Wire
News headline image
Nvidia To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Friday ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Via Benzinga
News headline image
Sanara MedTech Inc. Navigates Market Downturn Amidst "Undervalued" Consensus and Strategic Shifts
Via MarketMinute
News headline image
Sanara MedTech Inc (NASDAQ:SMTI) Reports Mixed Q2 2025 Results with Revenue Beat and Narrower Loss, Shares Surge 8.4% ↗
Via Chartmill
News headline image
Sanara MedTech Sales Jump 28 Percent ↗
Via The Motley Fool
News headline image
Levi Strauss To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Thursday ↗
Via Benzinga
News headline image
Where Sanara MedTech Stands With Analysts ↗
Via Benzinga
News headline image
Earnings Scheduled For March 25, 2025 ↗
Via Benzinga
News headline image
Earnings Scheduled For August 13, 2025 ↗
Via Benzinga
News headline image
Earnings Scheduled For May 14, 2025 ↗
Via Benzinga
News headline image
Biomimetic Innovations Ltd, an affiliate of PBC Biomed, Announces an Exclusive License and Distribution Agreement and Minority Investment with Sanara MedTech Inc.
From Biomimetic Innovations Ltd
Via GlobeNewswire
News headline image
SMTI Stock Earnings: Sanara MedTech Misses EPS, Beats Revenue for Q2 2024 ↗
Via InvestorPlace
News headline image
SMTI Stock Earnings: Sanara MedTech Misses EPS, Beats Revenue for Q1 2024 ↗
Via InvestorPlace
News headline image
SMTI Stock Earnings: Sanara MedTech Beats EPS, Beats Revenue for Q4 2023 ↗
Via InvestorPlace

Frequently Asked Questions

Is Sanara MedTech Inc. - Common Stock publicly traded?
Yes, Sanara MedTech Inc. - Common Stock is publicly traded.
What exchange does Sanara MedTech Inc. - Common Stock trade on?
Sanara MedTech Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Sanara MedTech Inc. - Common Stock?
The ticker symbol for Sanara MedTech Inc. - Common Stock is SMTI on the Nasdaq Stock Market
What is the current price of Sanara MedTech Inc. - Common Stock?
The current price of Sanara MedTech Inc. - Common Stock is 20.81
When was Sanara MedTech Inc. - Common Stock last traded?
The last trade of Sanara MedTech Inc. - Common Stock was at 06/12/26 04:00 PM ET
What is the market capitalization of Sanara MedTech Inc. - Common Stock?
The market capitalization of Sanara MedTech Inc. - Common Stock is 185.95M
How many shares of Sanara MedTech Inc. - Common Stock are outstanding?
Sanara MedTech Inc. - Common Stock has 186M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.